Can J Diabetes 39 (2015) 195e199
Contents lists available at ScienceDirect
Canadian Journal of Diabetes journal homepage: www.canadianjournalofdiabetes.com
Innovations in Diabetes Care
Internet Diabetes Management: A Practical Approach Hugh D. Tildesley MD a, *, Nelson Chow BSc b, Adam White MD a, Monika Pawlowska MD c, Stuart A. Ross MD d a
Division of Endocrinology, St Paul’s Hospital, Vancouver, British Columbia, Canada, and Department of Endocrinology and Metabolism, University of British Columbia, Vancouver, British Columbia, Canada Department of Biochemistry, University of British Columbia, Vancouver, British Columbia, Canada c Department of Endocrinology and Metabolism, University of British Columbia, Vancouver, British Columbia, Canada d Department of Medicine, University of Calgary, Calgary, Alberta, Canada b
Introduction Glycemic control is the core of diabetes care and is associated with reduced risk for complications in type 1 and type 2 diabetes (1e5). Randomized controlled clinical trials have shown that glycemic control reduces the chance for macrovascular and microvascular complications (3e5), so current treatment guidelines emphasize timely interventions for patients so they can reach appropriate glycemic targets within months of their diagnoses (6). However, more than half of North American patients remain above the glycemic target of glycated hemoglobin (A1C)
Contents lists available at ScienceDirect
Canadian Journal of Diabetes journal homepage: www.canadianjournalofdiabetes.com
Innovations in Diabetes Care
Internet Diabetes Management: A Practical Approach Hugh D. Tildesley MD a, *, Nelson Chow BSc b, Adam White MD a, Monika Pawlowska MD c, Stuart A. Ross MD d a
Division of Endocrinology, St Paul’s Hospital, Vancouver, British Columbia, Canada, and Department of Endocrinology and Metabolism, University of British Columbia, Vancouver, British Columbia, Canada Department of Biochemistry, University of British Columbia, Vancouver, British Columbia, Canada c Department of Endocrinology and Metabolism, University of British Columbia, Vancouver, British Columbia, Canada d Department of Medicine, University of Calgary, Calgary, Alberta, Canada b
Introduction Glycemic control is the core of diabetes care and is associated with reduced risk for complications in type 1 and type 2 diabetes (1e5). Randomized controlled clinical trials have shown that glycemic control reduces the chance for macrovascular and microvascular complications (3e5), so current treatment guidelines emphasize timely interventions for patients so they can reach appropriate glycemic targets within months of their diagnoses (6). However, more than half of North American patients remain above the glycemic target of glycated hemoglobin (A1C)
